|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Controversies still exist on the role of nighttime gastroesophageal reflux (GER) in precipitating nocturnal asthma. We tested the relationship between GER and nocturnal bronchoconstriction by continuously and simultaneously monitoring both respiratory resistances and esophageal pH in seven asthmatics with moderate to severe GER disease. Twenty-nine GER episodes were found during the study night lasting more than 5 min (LGER) and 72 not longer than 5 min (SGER). Both long (LGER) and short (SGER) gastroesophageal refluxes were able to maintain significantly higher lower respiratory resistances (RLR) at the resolution of each GER episode (RLRe) with respect to baseline values. RLR, expressed as the area under the RLR curve along each GER episode (AUCRLR) and as RLRe, showed significant correlations with GER duration. Moreover, a significant correlation was found between RLR measured 10 min after GER resolution and GER duration during each episode. We conclude that GER itself is able to elicit nocturnal bronchoconstriction in asthmatics with moderate to severe GER disease and that bronchoconstriction severity and duration are related to GER duration. Cuttitta G, Cibella F, Visconti A, Scichilone N, Bellia V, Bonsignore G. Spontaneous gastroesophageal reflux and airway patency during the night in adult asthmatics.
| |
INTRODUCTION |
|---|
|
|
|---|
Previous studies have reported a high incidence of gastroesophageal reflux (GER) among asthmatics (1, 2) and have also suggested that the treatment of reflux may result in marked improvement of asthma symptoms and pulmonary function (3- 6). In awake adult asthmatics with a positive Bernstein test, intraesophageal acid infusion has been reported to trigger bronchoconstriction with subsequent return toward baseline function when these symptoms were relieved with antacid treatment (7). Nighttime GER has been advocated as a possible causative and precipitating factor of nocturnal worsening of asthma: it can trigger changes in respiratory pattern in asthmatic children when asthma is complicated by the presence of esophagitis (8). Converserly, other reports present conflicting data. In fact, in a study based on the use of noninvasive methods, Hughes and coworkers reported that reflux did not play any role in the production of nighttime asthma symptoms (9). Similarly, Ekstrom and coworkers reported that GER does not play any important role as an immediate trigger factor in nocturnal asthma (10). Therefore, the relationship between GER and nocturnal asthma is still controversial: the heterogeneity of results may be partly due to methodological limitations in previous studies, in particular the need of waking up the patient to perform the functional measures. In addition, the selection of the samples in terms of severity of GER disease may have influenced the possibility of detecting any relationship with airway reactivity: in fact, the only study based on a reliable method (i.e., continuous and simultaneous measurement of airflow resistance and esophageal pH monitoring in nocturnal asthmatics) and reporting negative results was carried out on patients with mild GER disease (11). The aim of the present study was to test this hypothesis by applying proper techniques to the evaluation of the relationship between GER and nocturnal bronchoconstriction in asthmatics with moderate to severe GER disease.
| |
METHODS |
|---|
|
|
|---|
Sample
Seven adult lifelong nonsmokers affected by nonseasonal asthma (4 male, 3 female), as defined according to American Thoracic Society
(ATS) criteria (12), age 20 to 52 yr, were studied; all reported a personal history of heartburn, pain, and regurgitation suggesting GER
disease. The severity and the frequency of these symptoms were classified according to Vigneri and coworkers (13). Only subjects showing
a symptom score
12 were considered for the study.
Their main anthropometric and functional characteristics are presented in Table 1. All the subjects were affected by nocturnal asthma
as demonstrated by a fall in peak expiratory flow (PEF) values
15%
from bedtime to morning awakening and had not required changes in
medications during the last month before the study. All the subjects
reported awakenings associated with nocturnal asthma symptoms and,
frequently, with GER-related symptoms. All of them were receiving
regular inhaled corticosteroids and short-acting
2-agonists on an "as
needed" basis. None of them received theophylline or antacid, protonic pump inhibitors, H2-blockers, or prokinetics.
|
All patients gave written, informed consent, and approval for this study was granted by the institutional ethic committee.
Protocol
Each subject slept in the sleep laboratory and was submitted to a polysomnographic assessment. The following signals were continuously
recorded both on paper (Hewlett-Packard 7758B; Hewlett-Packard Co., Waltham, MA) and on tape recorder (Hewlett-Packard 3968A) for further playback and analysis: electroencephalogram, electro-oculogram and chin electromyogram, for conventional sleep staging (14); bidirectional oronasal airflow (
) by a light tight-fitting face mask
with a calibrated heated pneumotachograph (Fleisch no. 1) connected
to a differential pressure transducer (MP-45 Validyne, range ± 5 cm
H2O; Validyne, Northridge, CA); volume by electronic integration of
signal; transpulmonary pressure (PL) by a balloon-tipped catheter
placed in the lower third of the esophagus connected to a calibrated
differential pressure transducer (MP-45 Validyne, range ± 80 cm H2O)
referenced to the mask. The position of the esophageal catheter was
adjusted following the occlusion technique proposed by Baydur and
coworkers (15); supraglottic pressure (Psg) at supraglottic level by a
second balloon-tipped catheter positioned at a distance of 15 to 17 cm
from the nares and connected to a calibrated differential pressure
transducer (MP-45 Validyne, range ± 5 cm H2O) referenced to the
mask; esophageal pH by intraesophageal glass electrode (Proxima-Light; SensorMedics, Milano, Italy) placed 5 cm above the esophagogastric junction. The electrode was previously calibrated using a neutral buffer and an acid buffer of pH 4. The data of a pH meter were
recorded at a rate of 12 samples/min.
Analysis
Total lung resistance (RL) was computed breath-by-breath by the isovolume method using computer-based routines on a Digital Alpha Station (Digital Equipment Co., Maynard, MA): PL was referred to different flows at equal lung volumes (200 ml) (16); in this way, the elastic
component is made constant, and any pressure change can be referred
to flow-resistive properties. Supraglottic resistance (Rsg) was computed as the ratio between Psg and
. Lower respiratory resistance
(RLR) was derived breath-by-breath as the difference between RL and
Rsg and expressed as cm H2O · L
1 · s.
GER episodes were evaluated in terms of decreases in esophageal
pH below 4. They were separately evaluated on the basis of duration:
short GERs
5 min (SGER) and long GERs > 5 min (LGER). Because of its skewed distribution, the GER duration was expressed as
natural log (lnGER duration).
RLR at the start of the study night were measured while the patients were awake and in supine position. RLR were then analyzed as means per minute along the whole study night.
For each GER episode we calculated: RLR value during the minute
immediately preceding the GER onset (RLRb); the area under the RLR
curve (AUCRLR) computed as the area under the RLR values in each
GER episode; end RLR at the resolution of GER episode (RLRe);
RLRe
as the difference between RLRe and RLRb. AUCRLR was treated as natural log (lnAUCRLR) after transforming all negative values into positive
ones by adding 3.5 since the minimum raw AUC value was
2.5.
Because it has been suggested that GER effects on airway resistances may last until 10 min after the resolution of GER episode (17),
we also computed RLR 10 min after the resolution of episodes (RLR10'). For the latter analysis, when the time interval between GER
episodes was shorter than 10 min, more GER were pooled together:
in this case, RLRb was the RLR value immediately preceding the first
GER; the
RLR10' was again calculated as the difference between RLR
at 10 min after GER resolution and RLRb. The GER duration was assumed as the sum of the durations of all pooled GER episodes within
such an event.
Differences between means were evaluated by two-way analysis of
variance (two-way ANOVA), to take into account both differences between variables and between subjects. In order to know whether each GER episode was associated with RLR increases within the individual, we removed the differences between subjects looking only at
changes within. Accordingly, correlations between lnAUCRLR,
RLRe,
and
RLR10' as outcome variables and lnGER as predictor one were
evaluated by analysis of covariance, introducing our data in a multiple
linear regression model. Each subject was treated as a categorical factor using dummy variables (18). Moreover, to investigate the relationships between AUCRLR and
RLRe as outcome variables and subject
number, GER duration, wake-sleep state, and RLRb as predictor ones
we used a stepwise logistic multiple regression model. The AUCRLR
and
RLRe were dichotomized using a threshold corresponding to the
50th percentile of each variable distribution, whereas the independent
variables were transformed in dummy variables as in Table 2. For each
of the two outcomes (AUCRLR and
RLRe), all correlates at univariate
analysis were entered into a stepwise logistic regression analysis. Variables were considered to be independent predictors of the outcome if the odds ratio differed from 1 and the 95% confidence limits did not
include 1. All the statistical procedures were performed by Systat
(Systat Inc., Evanston, IL) and Stata (Stata Corporation, College Station, TX) software packages.
|
| |
RESULTS |
|---|
|
|
|---|
The median total experimental time (TET) for all the subjects was 423 min (range 301 to 502); the median total sleep time was 194 (range 60 to 296). Table 3 shows total experimental and sleep time for all the subjects, with median sleep stage duration. Rapid eye movement (REM) sleep was observed only in one subject (BON).
|
During the study night, a total of 101 GER episodes were found and analyzed in the overall sample: 72 were SGER (median 1.0 min) and 29 LGER (median 9.0 min, range 6 to 41). Median time spent in GER was 17.1% of TET (range 7.1 to 39.7).
The mean RLR at the beginning of study night (patients
awake and in supine position) was 11.8 ± 3.7 cm H2O · L
1 · s
(Table 1). The overall trend of RLR over the time in these patients showed instantaneous increases when GER episodes
occurred and a subsequent decrease after the resolution of
GER episodes. Conversely, not all the increases in RLR occurred after a GER episode. Figures 1A and 1B present the
RLR trend during the night for two representative subjects
(BON and PRE).
|
Table 4 shows individual GER duration in absolute time and as percent of relevant sleep stages.
|
By the two-way ANOVA we found significant differences
between RLRe and RLRb both in SGER and LGER (Table 5);
moreover, both AUCRLR and
RLR10' values were found to be
significantly higher in LGER with respect to SGER (p < 0.0001 for both).
|
The analysis of covariance showed highly significant correlations between lnAUCRLR,
RLRe, and
RLR10' as outcome
variables versus lnGER duration as predictor one (Table 6,
and Figures 2-4). A weak subject effect was noted only for the
RLRe versus lnGER duration relationship.
|
|
|
|
The stepwise logistic regression analysis showed that no effect was produced by subjects' GER duration, wake-sleep
state, and RLRb on AUCRLR and on
RLRe, the GER duration
being the only significant predictor for RLR increase.
| |
DISCUSSION |
|---|
|
|
|---|
The present study, based on the direct, continuous, and simultaneous evaluation of both respiratory resistances and intraesophageal pH during nighttime, demonstrates a significant role of spontaneous GER episodes in provoking and sustaining nocturnal bronchoconstriction in adult asthmatics with moderate to severe GER disease. In fact, we found that: (1) GER episodes are associated with significant RLR increase; (2) RLR increases are strongly related with GER duration; (3) RLR increases tend to be maintained for a while after GER episode termination. These results are in agreement with previous studies suggesting that GER may be an important trigger mechanism in asthmatic children with nocturnal wheezing (8, 19). A further indirect evidence of the potential role played by GER in asthma has been provided by Harding and coworkers, who demonstrated the effect of long-term antacid therapy in improving asthma symptoms and pulmonary function (3).
Previous studies on the relationship between GER and nocturnal asthma reported controversial results probably owing to different factors. First, complete awakening of the patient is required when a functional index such as PEF is used to monitor nocturnal bronchoconstriction (10); the effect of sleep disruption on airway tone is unpredictable, and a lack of temporal correspondence is produced between acid stimulation on esophageal mucosa and the recorded modification of the functional index. Second, other indexes used to avoid sleep disruption (such as continuous transcutaneous monitoring of oxygen saturation) yield only indirect evidence of bronchoconstriction (8, 19). A third factor is the choice of the population sample: our results seem to demonstrate that the severity of GER disease is an important factor to produce a clear bronchoconstrictive effect, as previously reported (19).
The changes in airway patency found in our study (i.e., significant RLR increase strongly related with GER duration and rapid, even if not immediate, decline after GER termination) may explain the negative results obtained in studies based on measures of respiratory function not simultaneous with GER, and requiring the waking up of the patient (9, 10). These negative results may be further explained on the basis of the low sensitivity of methods used to detect bronchoconstriction. Moreover, the rapid response in terms of RLR changes supports more the hypothesis of a vagal reflex as pathogenetic mechanism originating from irritant esophageal mucosal receptors (20), than that of gastric content aspiration into the airways (21, 22).
The time course of changes in resistances with the development of RLR increases when GER episodes occurred (Figure
1) seems to lend some support to the effect of GER duration
on the degree (Figures 2-4) of bronchoconstriction. This assumption is founded on the significant correlations between
AUCRLR and
RLRe with GER duration. Two-way ANOVA
showed significant differences in AUCRLR and
RLR10' values
between GER episodes of different length: these results indicate that LGER have a significant effect on RLR increase and
on its persistence after GER termination. A significant effect
on RLR may also result from GER episodes lasting not more
than 5 min, as shown by the significant increase in RLRe in
SGER, even if the bronchoconstrictor effect is lower owing to
the shorter duration.
The importance of duration of GER is confirmed by the
fact that the higher the lnGER duration, the more prolonged
is the effect on airways 10 min after GER termination, as expressed by higher
RLR10' (Figure 4). This suggests on one
hand a slower recovery of pulmonary function after acid is
cleared from the esophagus (23), on the other a delayed bronchoconstrictor effect due to bronchial inflammation (late-phase reaction) reflecting inflammatory mediator release (21).
The wake-sleep status seems to have no impact on the bronchoconstrictor effect of GER episodes as confirmed by the
stepwise logistic regression analysis.
With regard to the effect of choice of population sample on the results, the only previous nocturnal investigation methodologically comparable to ours found no relationship between spontaneous or simulated GER and nocturnal increase in respiratory resistances, either in presence or in absence of esophagitis; the investigators concluded that GER produces only a poor contribution to nocturnal asthma worsening. However, that study was carried out on asthmatic patients affected by GER disease with a lower number of GER episodes during the night and a lower mean duration (11): a total of 11 GER episodes during the night were reported with a mean duration of 10.4 ± 2.3 min (range 1.1 to 24.0) and a mean total reflux time of 19.1 ± 5.7 min (84 min in our study) or 5.4% ± 1.4 of TET (17.1% in our study).
In conclusion, GER itself seems to be able to elicit a clinically relevant nocturnal bronchoconstriction in asthmatic subjects. Bronchoconstriction severity and duration are related to GER duration; in fact, longer GER episodes produced greater and more prolonged increases in RLR. Conversely, the finding of a minority of GER-unrelated bronchoconstriction events suggests that GER represents just one component of a host of factors whose complex interaction results in the clinical phenomenon of nocturnal asthma.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Giuseppina Cuttitta, M.D., Istituto di Fisiopatologia Respiratoria del CNR, Via Trabucco, 180, I 90146 Palermo, Italy. E-mail: cibella{at}ifrpa.ifr.pa.cnr.it
(Received in original form August 6, 1998 and in revised form July 20, 1999).
| |
References |
|---|
|
|
|---|
1. Harding, S. M., and J. E. Richter. 1992. Gastroesophageal reflux disease and asthma. Semin. Gastrointest. Dis. 3: 139-150 .
2. Sontag, S. J., S. O'Connell, S. Khandelwal, T. Miller, B. Nemchausky, T. G. Schnell, and R. Serlovsky. 1990. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 99: 613-620 [Medline].
3. Harding, S. M., J. E. Richter, M. R. Guzzo, C. A. Schan, R. W. Alexander, and L. A. Bradley. 1996. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am. J. Med. 100: 395-405 [Medline].
4. Sontag, S. J.. 1990. The medical management of reflux esophagitis: role of antacids and acid inhibition. Gastroenterol. Clin. North Am. 19: 683-712 [Medline].
5. Tucci, F., M. Resti, R. Fontana, E. Novembre, C. A. Lami, and A. Vierucci. 1993. Gastroesophageal reflux and bronchial asthma: prevalence and effect of cisapride therapy. J. Pediatr. Gastroenterol. Nutr. 17: 265-270 [Medline].
6. Ford, G. A., P. S. Oliver, J. S. Prior, R. J. Butland, and S. P. Wilkinson. 1994. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastroesophageal reflux: a placebo-controlled cross-over study. Postgrad. Med. J. 70: 350-354 [Abstract].
7. Spaulding, H. S. Jr., L. E. Mansfield, M. R. Stein, J. C. Sellner, and D. E. Gremillion. 1982. Further investigation of the association between gastroesophageal reflux and bronchoconstriction. J. Allergy Clin. Immunol. 69: 516-521 [Medline].
8. Davis, R. S., G. L. Larsen, and M. M. Grunstein. 1983. Respiratory response to intraesophageal acid infusion in asthmatic children during sleep. J. Allergy Clin. Immmunol. 72: 393-398 [Medline].
9. Hughes, D. M., S. Spier, J. Rivlin, and H. Levison. 1983. Gastroesophageal reflux during sleep in asthmatic patients. J. Pediatr. 102: 666-672 [Medline].
10. Ekstrom, T., and L. Tibbling. 1987. Gastroesophageal reflux and triggering of bronchial asthma: a negative report. Eur. J. Respir. Dis. 71: 177-180 [Medline].
11. Tan, W. C., R. J. Martin, R. Pandey, and R. D. Ballard. 1990. Effects of spontaneous and simulated gastroesophageal reflux on sleeping asthmatics. Am. Rev. Respir. Dis. 141: 1394-1399 [Medline].
12. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 36: 225-244 .
13.
Vigneri, S.,
R. Termini,
G. Leandro,
S. Badalamenti,
M. Pantalena,
V. Savarino,
F. Di Mario,
G. Battaglia,
G. S. Mela,
A. Pilotto,
M. Plebani, and
G. Davi.
1995.
A comparison of five maintenance therapies
for reflux esophagitis.
N. Engl. J. Med.
333:
1106-1110
14. Rechtschaffen, A., and A. Kales. 1968. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. BIS/BRI, UCLA Press, Los Angeles.
15. Baydur, A., P. K. Behrakis, W. A. Zin, M. Jaeger, and J. Milic-Emili. 1982. A simple method for assessing the validity of the esophageal balloon technique. Am. Rev. Respir. Dis. 126: 788-791 [Medline].
16. Frank, N. R., J. Mead, and B. G. Ferris. 1957. The mechanical behaviour of the lungs in healthy elderly persons. J. Clin. Invest. 36: 1680-1687 .
17. Sontag, S. J. 1991. Pulmonary abnormalities and gastroesophageal disease. In J. E. Richter, editor. Ambulatory Esophageal pH Monitoring: Practical Approach and Clinical Applications. Igaku-Shoin, New York. 151-166.
18.
Bland, J. M., and
D. G. Altman.
1995.
Calculating correlation coefficients with repeated observations: Part 1
Correlation within subjects.
B.M.J.
310:
446
19. Martin, M. E., M. M. Grunstein, and G. L. Larsen. 1982. The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. Ann. Allergy 49: 318-322 [Medline].
20.
Lodi, U.,
S. M. Harding,
H. C. Coghlan,
M. R. Guzzo, and
L. H. Walker.
1997.
Autonomic regulation in asthmatics with gastroesophageal reflux.
Chest
111:
65-70
21.
Harding, S. M.,
C. A. Schan,
M. R. Guzzo,
R. W. Alexander,
L. A. Bradley, and
J. E. Richter.
1995.
Gastroesophageal reflux-induced bronchoconstriction: is microaspiration a factor?
Chest
108:
1220-1227
22. Cucchiara, S., F. Santamaria, R. Minella, E. Alfieri, A. Scoppa, F. Calabrese, M. T. Franco, B. Rea, and G. Salvia. 1995. Simultaneous prolonged recordings of proximal and distal intraesophageal pH in children with gastroesophageal reflux disease and respiratory symptoms. Am. J. Gastroenterol. 90: 1791-1796 [Medline].
23.
Schan, C. A.,
S. M. Harding,
J. M. Haile,
L. A. Bradley, and
J. E. Richter.
1994.
Gastroesophageal reflux-induced bronchoconstriction: an
intraesophageal acid infusion study using state-of-the-art technology.
Chest
106:
731-737
This article has been cited by other articles:
![]() |
T. O. Kiljander, S. M. Harding, S. K. Field, M. R. Stein, H. S. Nelson, J. Ekelund, M. Illueca, O. Beckman, and M. B. Sostek Effects of Esomeprazole 40 mg Twice Daily on Asthma: A Randomized Placebo-controlled Trial Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1091 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fass, S. F. Quan, G. T. O'Connor, A. Ervin, and C. Iber Predictors of Heartburn During Sleep in a Large Prospective Cohort Study Chest, May 1, 2005; 127(5): 1658 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casanova, J.S. Baudet, M. del Valle Velasco, J.M. Martin, A. Aguirre-Jaime, J. Pablo de Torres, and B.R. Celli Increased gastro-oesophageal reflux disease in patients with severe COPD Eur. Respir. J., June 1, 2004; 23(6): 841 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Calhoun Nocturnal Asthma Chest, March 1, 2003; 123(2007): 399S - 405S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Lazenby, M. R. Guzzo, S. M. Harding, P. E. Patterson, L. F. Johnson, and L. A. Bradley Oral Corticosteroids Increase Esophageal Acid Contact Times in Patients With Stable Asthma Chest, February 1, 2002; 121(2): 625 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF] |
||||
![]() |
R. A. Incalzi, V. Bellia, F. Catalano, N. Scichilone, C. Imperiale, S. Maggi, and F. Rengo Evaluation of Health Outcomes in Elderly Patients With Asthma and COPD Using Disease-Specific and Generic Instruments : The Salute Respiratoria nell'Anziano (Sa.R.A.) Study Chest, September 1, 2001; 120(3): 734 - 742. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |